Cargando…
Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand
BACKGROUND: Cannabidiol (CBD) is the non-euphoriant component of cannabis. In 2017, the New Zealand Misuse of Drugs Regulations (1977) were amended, allowing doctors to prescribe CBD. Therapeutic benefit and tolerability of CBD remains unclear. AIM: To review the changes in self-reported quality of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Royal College of General Practitioners
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330185/ https://www.ncbi.nlm.nih.gov/pubmed/32019776 http://dx.doi.org/10.3399/bjgpopen20X101010 |